Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ECO-04601 inhibits tumor growth in animal model of glioma

Feb. 4, 2004

Survival benefit found with tesmilifene plus doxorubicin in recurrent/metastatic breast cancer

Feb. 4, 2004

New vitamin D-based CYP24 inhibitors and their use claimed by Johns Hopkins U. and Cytochroma

Feb. 4, 2004

Novel antiangiogenic agents covered by Pfizer patent

Feb. 4, 2004

Novuspharma team identifies new VEGF production inhibitors

Feb. 4, 2004

Novel PARP inhibitors prepared and tested at Pfizer

Feb. 4, 2004

Department of Defense award for vaccine technology development at Generex

Feb. 3, 2004

Photodynamic therapy in combination with DMXAA shows promising therapeutic advantages

Feb. 3, 2004

Pfizer team presents novel GnRH antagonists in a recent patent

Feb. 3, 2004

Merck presents novel KSP inhibitors with utility in cancer therapy

Feb. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.